Conjugation of the anti-DEC-205 monoclonal antibody to the melanoma antigen tyrosinase-related protein TRP-2, induced CD4+ and CD8+ T-cell responses which protected mice against B16 tumor cell growth and slowed growth of established B16 tumors [177]. This evidence concerns the gene CD8A and melanoma.